Search results for "index" ( 4 records found )

A Public Health Seminar, delivered on Monday, April 18, 2011, titled: "Intimate Partner Violence: Identification and Interventions Current Research", delivered by Debra Houry, MD, MPH Director, Center for Injury Control Vice Chair for Research, Emergency Medicine Emory University, Atlanta, Georgia. Recent systematic reviews have noted a lack of evidence that screening for intimate partner violence does more good than harm. Dr. Houry will talk about her study using a computer kiosk for identification and referral of intimate partner violence in the ED setting resulted in safety behaviors or contact with referrals. Her team conducted a prospective, observational study in which a convenience sample of male and female ED patients triaged to the waiting room who screened positive (on a computer kiosk-based questionnaire) for intimate partner violence were provided with resources and information and invited to participate in a series of follow-up interviews. At 1-week and 3-month follow-up visits, they assessed intimate partner violence, safety issues, and use of resources. In addition, to obtain an objective measure of safety, we assessed the number of violence-related 911 calls to participant addresses within a call district 6 months before and 6 months after the index ED visit. The team found there were no identified adverse events related to screening, and many had contacted community resources.

A Public Health Seminar, delivered on Monday, April 18, 2011, titled: "Intimate Partner Violence: Identification and Interventions Current Research", delivered by Debra Houry, MD, MPH Director, Center for Injury Control Vice Chair for Research, Emergency Medicine Emory University, Atlanta, Georgia. Recent systematic reviews have noted a lack of evidence that screening for intimate partner violence does more good than harm. Dr. Houry will talk about her study using a computer kiosk for identification and referral of intimate partner violence in the ED setting resulted in safety behaviors or contact with referrals. Her team conducted a prospective, observational study in which a convenience sample of male and female ED patients triaged to the waiting room who screened positive (on a computer kiosk-based questionnaire) for intimate partner violence were provided with resources and information and invited to participate in a series of follow-up interviews. At 1-week and 3-month follow-up visits, they assessed intimate partner violence, safety issues, and use of resources. In addition, to obtain an objective measure of safety, we assessed the number of violence-related 911 calls to participant addresses within a call district 6 months before and 6 months after the index ED visit. The team found there were no identified adverse events related to screening, and many had contacted community resources.

Recorded on November 22, 2010. Acknowledgment This presentation is made possible by the UC Irvine Framework Program in Global Health, funded by the Fogarty International Center of the National Institutes of Health (http://publichealth.uci.edu/gh_docs/index). Abstract Every 30 seconds, a child in Africa dies from malaria, a parasitic infection initiated by the bite of a mosquito. According to the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), up to 300 million cases of malaria occur worldwide, resulting in approximately 1 million premature deaths, mostly of children under the age of 5 years in sub- Saharan Africa. But the geography of malaria burden extends to Asia and South America. Rapid population movement, environmental changes, and inability to deploy effective prevention strategies threaten to increase the range and severity of the disease. Target 6C of the United Nations Millennium Development Goals (MDG) aims to halt or begin to reverse the incidence of malaria by the year 2015. Is this an achievable goal? There are many tools in the scientific box, but great uncertainty on how to deploy them. There is Word document to permit you to carry out the exercise here. http://cast.nacs.uci.edu/ocw/collections/public_health/2010_UCI_Exercise_Objective.doc. Biography Dr. Mark Q. Benedict is a consultant to the Gates Foundation project on the application of transgenic mosquitoes for malaria control through induced sterility of disease vectors. He was a Research Medical Entomologist at the International Atomic Energy Agency in Vienna, Austria where he managed the mosquito sterile insect technique development program and field activities in Sudan and Reunion Island. For more than ten years, he worked at the CDC’s MR4 facility (Malaria Research and Reference Agent Center), and as a MacArthur Foundation Vector-Biology Network-sponsored fellow.

Acknowledgment This presentation is made possible by the UC Irvine Framework Program in Global Health, funded by the Fogarty International Center of the National Institutes of Health (http://publichealth.uci.edu/gh_docs/index). Abstract Every 30 seconds, a child in Africa dies from malaria, a parasitic infection initiated by the bite of a mosquito. According to the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), up to 300 million cases of malaria occur worldwide, resulting in approximately 1 million premature deaths, mostly of children under the age of 5 years in sub- Saharan Africa. But the geography of malaria burden extends to Asia and South America. Rapid population movement, environmental changes, and inability to deploy effective prevention strategies threaten to increase the range and severity of the disease. Target 6C of the United Nations Millennium Development Goals (MDG) aims to halt or begin to reverse the incidence of malaria by the year 2015. Is this an achievable goal? There are many tools in the scientific box, but great uncertainty on how to deploy them. There is Word document to permit you to carry out the exercise here. http://cast.nacs.uci.edu/ocw/collections/public_health/2010_UCI_Exercise_Objective.doc. Biography Dr. Mark Q. Benedict is a consultant to the Gates Foundation project on the application of transgenic mosquitoes for malaria control through induced sterility of disease vectors. He was a Research Medical Entomologist at the International Atomic Energy Agency in Vienna, Austria where he managed the mosquito sterile insect technique development program and field activities in Sudan and Reunion Island. For more than ten years, he worked at the CDC’s MR4 facility (Malaria Research and Reference Agent Center), and as a MacArthur Foundation Vector-Biology Network-sponsored fellow.